XM does not provide services to residents of the United States of America.

Indian equities are primed for a drab few months, GS says



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>LIVE MARKETS-Indian equities are primed for a drab few months, GS says</title></head><body>

STOXX down 0.3%

Nasdaq futures down 0.4%, S&P 500 futures down 0.3%

Nvidia forecast its slowest revenue growth in seven quarters

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.

INDIAN EQUITIES ARE PRIMED FOR A DRAB FEW MONTHS, GS SAYS

Indian stocks have had a rough few weeks recently, and though the outlook for emerging markets globally look cloudy, strategists at Goldman Sachs point to a few pockets that could weather the storm.

The brokerage forecasts economic growth to slow to 6.3% in the south Asian economy next year due to tighter fiscal spending and weak credit growth held back by a slow pace of monetary policy easing.

The result could be weak earnings for stocks on the MSCI Indian equities index .dMIIN00000PUS that are already sitting at high valuations. Stock returns are projected to be muted for the next three to six months.

Price to earnings valuation for the Sensex index .BSESN stands at 22.3x and is expected to be 21.83x over the next one year, according to LSEG data.

The brokerage expects the index to touch 24,000 over the next three months and hit 27,000 in case of a recovery by year-end - an about 15% upside from last close.

"Sectorally, we expect financials, telcos, autos, metals and IT to be the major contributors to the overall index earnings next year," GS strategists led by Sunil Koul said as they maintained a "neutral" rating on the country.

One silver lining could be that the brokerage sees India as comparatively insulated from possible tariffs that the upcoming Donald Trump administration in the U.S. could slap on trade partners, simply because only 2% of India's MSCI goods revenue and 4% of services revenue come from the U.S..

Against this backdrop, the brokerage upgrades exporters including infotech and pharma companies to "overweight" on the likelihood of export revenue to be aided by a weaker rupee INR=IN against the dollar.

Indian markets have faced foreign investor selling following signs of policy support out of China with the Nifty index marking a correction - a 10% decline from September's record highs when year-to-date gains touched around 20%.

In the near-term Goldman Sachs says market could experience support from consistent strong domestic buying which could thwart any steep price corrections even as foreign investors are unlikely to return in a strong dollar environment.

(Johann M Cherian)

*****

EARLIER LIVE MARKETS POSTS

BUYBACKS TO HELP LAGGING EUROPE CLICK HERE

HOPE YOU'RE KEEPING UP CLICK HERE

EUROPE BEFORE THE BELL: BUSY BUSY CLICK HERE


Barclays buybacks https://tmsnrt.rs/3ZhU5vd

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.